Two Novel Long Noncoding RNAs – RP11-296E3.2 and LEF1-AS1can – Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer-Reference-Cited by-同舟云学术

Two Novel Long Noncoding RNAs – RP11-296E3.2 and LEF1-AS1can – Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer

Published:2019-09-19 Issue: Volume:25 Page:7042-7051
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Shi Qian¹,He Ying¹,Zhang Xilin¹,Li Jingjing²,Cui Ge¹,Zhang Xiuping³,Wang Xiang¹

Affiliation:

1. First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China (mainland)

2. Key Laboratory of Nutrition, Metabolism, and Food Safety, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (mainland)

3. Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications;International Journal of Molecular Sciences;2024-03-15

2. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers;Clinical and Experimental Medicine;2024-01-31

3. Colon cancer transcriptome;Progress in Biophysics and Molecular Biology;2023-07

4. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3;Journal of Translational Medicine;2023-06-27

5. LncRNAs in colorectal cancer: Biomarkers to therapeutic targets;Clinica Chimica Acta;2023-03